Notice for pegcetacoplan (Swedish Orphan Biovitrum Pty Ltd)
Active ingredients
pegcetacoplan
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
solution for injection
Indication
For the treatment of C3 glomerulopathy with or without immune complexes
Therapeutic area
Nephrology